Electrocardiographic Changes of Sinoatrial Dysfunction in Hypoglycemia: A Case Report

Authors

  • Luis Alberto Rodríguez López Pre-surgical Cardiology Service. “Ernesto Che Guevara” Cardiocenter Hospital. Santa Clara, Villa Clara, Cuba Author
  • Yendry Gattorno Águila Cardiology Service. Althaia Foundation, Manresa, Barcelona, Spain Author
  • Alejandra González Esquerra Cardiology Resident. Arnaldo Milián Castro Clinical-Surgical Hospital. Santa Clara, Cuba Author
  • Marlon Durán Cárdenas Internal Medicine Resident. Arnaldo Milián Castro Clinical-Surgical Hospital. Santa Clara, Cuba Author
  • Daniella Camacho Leandro Intensive Care Medicine Resident. Arnaldo Milián Castro Clinical-Surgical Hospital. Santa Clara, Cuba Author

DOI:

https://doi.org/10.56294/shp2024398

Keywords:

Sinoatrial dysfunction, sinus pause, hypoglycemia

Abstract

Acute and chronic hypoglycemia, induced by insulin or oral antidiabetic agents in a therapeutic context, is a cardiovascular risk factor that triggers endothelial dysfunction and atherogenesis via pro-inflammatory mechanisms. It may be equally or more relevant than hyperglycemia, with the added threat of inducing arrhythmogenic and ischemic sudden death.
We present the case of a 61-year-old female patient with a medical history of diabetes mellitus, managed with long-acting insulin (30 units in the morning and 15 units at night), who developed fever, general malaise, and anorexia, followed by an episode of near syncope accompanied by profuse sweating. She was taken to the emergency department, where capillary blood glucose was found to be 2.4 mmol/L. A 12-lead ECG revealed sinus pauses, which resolved following administration of hypertonic dextrose.
This case illustrates that hypoglycemia poses a real threat to the myocardium, not only due to its immediate proarrhythmic effects (linked to sudden death syndrome) but also due to its long-term proinflammatory and atherogenic effects, representing a major cardiovascular risk factor. Therefore, it is desirable and clinically pertinent to avoid hypoglycemic episodes of any intensity or duration in all diabetic patients—particularly those with underlying myocardial pathologies that increase the risk of sudden death: compromised systolic function, ventricular arrhythmias, atrial fibrillation, coronary artery disease, hypertrophic cardiomyopathy, arrhythmogenic genotype, and history of resuscitation.

References

ALAD Guidelines for the Diagnosis, Control, and Treatment of Type 2 Diabetes Mellitus Based on Evidence-Based Medicine. 2013 Edition. Rev ALAD. 2013;1–142.

Bruce DG, Davis WA, Casey GP. Severe hypoglycemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia. 2009;52:1808–1815.

ADVANCE Study. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–2572.

Mannucci E, Monami M, Lamanna C, Gori F, Marchionni N. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis. 2009;19:604–612.

ACCORD Study. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364:818–828.

ACCORD Study. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–2559.

Warren RE, Frier BM. Hypoglycaemia and cognitive function. Diabetes Obes Metab. 2005;7:493–503.

Fisher BM, Heller SR. Mortality, cardiovascular morbidity and possible effects of hypoglycaemia on diabetic complications. In: Frier BM, Fisher M, eds. Hypoglycaemia in Clinical Diabetes. 2nd ed. Chichester: John Wiley and Sons; 2007:265–283.

Frier BM, Schernthaner G, Heller SR. Hypoglycemia and cardiovascular risks. Diabetes Care. 2011;34 Suppl:S132–S137.

Chow E, Bernjak A, Williams S, Fawdry RS, Hibbert S, Freeman J, et al. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes. 2014;63:1738–1747.

Lim VG, Yip KP, Lim ZY, Sporton S, Kennon S. The ‘Normal’ Heart: Fascicular Ventricular Tachycardia. Am J Med. 2016.

Rivero Ayerza M, Femenía F. Ablation of idiopathic ventricular tachycardias. In: Brugada J, Aguinaga L. Catheter Ablation of Cardiac Arrhythmias. Chapter 8.

Paraskevaidis S, Theofilogiannakos EK, Konstantinou DM, Mantziari L, Kefalidis C, Megarisiotou A, et al. Narrow QRS complex in idiopathic (fascicular) left ventricular tachycardia. Herz. 2015.

Castro Hevia J, Dorticós Balea F, Zayas Molina R, Dorantes Sánchez M, Rodríguez Marture F. Left fascicular ventricular tachycardia: report of 2 cases. Rev Cubana Cardiol Cir Cardiovasc. 1998;12(1):13–19.

Liu Y, Fang Z, Yang B, Kojodjojo P, Chen H, Ju W, et al. Catheter ablation of fascicular ventricular tachycardia: long-term clinical outcomes and mechanisms of recurrence. Circ Arrhythm Electrophysiol. 2015 Sep 18.

Chapman AB, Abraham WT, Zamudio S, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 1998;54:2056.

Meah VL, Cockcroft JR, Backx K, et al. Cardiac output and related hemodynamics during pregnancy: a series of meta-analyses. Heart. 2016;102:518.

Green LJ, Mackillop LH, Salvi D, et al. Gestation-specific reference ranges for vital signs in pregnancy. Obstet Gynecol. 2020;135:653.

Tan H, Lie K. Treatment of tachyarrhythmias during pregnancy and lactation. Eur Heart J. 2001;22:458–464.

Downloads

Published

2025-06-15

How to Cite

1.
Rodríguez López LA, Gattorno Águila Y, González Esquerra A, Durán Cárdenas M, Camacho Leandro D. Electrocardiographic Changes of Sinoatrial Dysfunction in Hypoglycemia: A Case Report. South Health and Policy [Internet]. 2025 Jun. 15 [cited 2025 Aug. 19];4:398. Available from: https://shp.ageditor.ar/index.php/shp/article/view/398